Nina Hobi, AlveoliX AG - Qepler Summits And Conferences

Nina Hobi

CEO & Scientific Director
AlveoliX AG
Bern, Switzerland
AlveoliX AG

Related Sessions:

2nd Annual Inhaled
Drug Delivery Summit 2020

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 17 Sep 2020
  • Prague, CZ
  • Pharma
Day 1: Thursday, 17 September 2020
CASE STUDY: Lung on chip applicatons in risperatory health.
View Details